Innocan Pharma Introduction Video
A Video Guru Production https://www.vdo.guru/
Innocan Pharma Video Script V15
Innocan Pharma combines vast pharmaceutical know-how and experience with highly innovative delivery systems, bringing to market a new generation of CBD integrated pharmaceutical products.
A public company, it’s listed the on Canadian Securities Exchange, under INNO and on the Frankfurt Stock Exchange underFRA: IP4.
Innocan Pharma is led by a multi-disciplinary management and R&D team, headed by:
Iris Bincovich, an experienced healthcare Executive, Ron Mayron, former CEO of Teva Israel, one of the largest generic pharmaceutical company in the world. Yoram Drucker Founder of two Nasdaq traded companies – Pluristem & Brainstorm, working with stem cells, Nir Avram, former member of the pharma innovation team at Perrigo, Prof. Chezy Barenholz, Head of the Laboratory of Membrane and Liposome Research of the Hebrew University – Jerusalem and Prof. Daniel Offen, a leading researcher specializing in Neuroscience and Exosome technology, Head of the Department of Human Molecular Genetics and Biochemistry at Tel Aviv University.
COVID-19, the Corona Virus, is a new, rapidly growing worldwide threat, mainly affecting the lungs.
Innocan, together with Tel Aviv University Prof. Offen and his team, are developing new, revolutionary Cell Therapy - based technology, loaded with CBD, that design to targets Corona Virus infected lung cells and Central Nervous System diseases.
CBD-Loaded Exosomes hold the potential to provide a highly synergistic effect of anti-inflammatory properties and help in the recovery of infected lung cells.
This product, which is expected to be administrated by inhalation, will be tested on a variety of lung infections focusing on patients infected by the corona Virus.
Exosome are small particles created when stem cells are multiplied. It’s been found that Exosomes may target damaged tissue in the lungs when infected by the Corona virus and repairing damaged cells.
Prof. Offen’s team showed great success using Exosomes as a targeted drug delivery system specifically to damaged cells. Together we are developing a novel and revolutionary treatment for the Corona Virus. This product is planned to act as a "homing missile" to the infected lungs, combining the cell healing properties of the Exosome and the anti-inflammatory properties of CBD.
Simultaneously, Innocan is advancing it’s R&D of a revolutionary platform for injectable CBD loaded liposomes in collaboration with Prof. Barenholz of the Hebrew University of Jerusalem
This accurate, controlled administration of CBD by injection, is expected to be as easy as injecting insulin.
In addition to this ground-breaking research, Innocan Pharma develops and manufactures:
Shir Beauty & Science – a premium CBD derma cosmetic brand.
R&G Relief & Go – a breakthrough patent-pending CBD pain relief brand.
InnoCan seeks to integrate the huge therapeutic potential of Cannabinoid, with smart synergetic combinations and delivery systems, to make an impact on global health and wellbeing.
Join us!
Innocan Pharma Video Script V15
Innocan Pharma combines vast pharmaceutical know-how and experience with highly innovative delivery systems, bringing to market a new generation of CBD integrated pharmaceutical products.
A public company, it’s listed the on Canadian Securities Exchange, under INNO and on the Frankfurt Stock Exchange underFRA: IP4.
Innocan Pharma is led by a multi-disciplinary management and R&D team, headed by:
Iris Bincovich, an experienced healthcare Executive, Ron Mayron, former CEO of Teva Israel, one of the largest generic pharmaceutical company in the world. Yoram Drucker Founder of two Nasdaq traded companies – Pluristem & Brainstorm, working with stem cells, Nir Avram, former member of the pharma innovation team at Perrigo, Prof. Chezy Barenholz, Head of the Laboratory of Membrane and Liposome Research of the Hebrew University – Jerusalem and Prof. Daniel Offen, a leading researcher specializing in Neuroscience and Exosome technology, Head of the Department of Human Molecular Genetics and Biochemistry at Tel Aviv University.
COVID-19, the Corona Virus, is a new, rapidly growing worldwide threat, mainly affecting the lungs.
Innocan, together with Tel Aviv University Prof. Offen and his team, are developing new, revolutionary Cell Therapy - based technology, loaded with CBD, that design to targets Corona Virus infected lung cells and Central Nervous System diseases.
CBD-Loaded Exosomes hold the potential to provide a highly synergistic effect of anti-inflammatory properties and help in the recovery of infected lung cells.
This product, which is expected to be administrated by inhalation, will be tested on a variety of lung infections focusing on patients infected by the corona Virus.
Exosome are small particles created when stem cells are multiplied. It’s been found that Exosomes may target damaged tissue in the lungs when infected by the Corona virus and repairing damaged cells.
Prof. Offen’s team showed great success using Exosomes as a targeted drug delivery system specifically to damaged cells. Together we are developing a novel and revolutionary treatment for the Corona Virus. This product is planned to act as a "homing missile" to the infected lungs, combining the cell healing properties of the Exosome and the anti-inflammatory properties of CBD.
Simultaneously, Innocan is advancing it’s R&D of a revolutionary platform for injectable CBD loaded liposomes in collaboration with Prof. Barenholz of the Hebrew University of Jerusalem
This accurate, controlled administration of CBD by injection, is expected to be as easy as injecting insulin.
In addition to this ground-breaking research, Innocan Pharma develops and manufactures:
Shir Beauty & Science – a premium CBD derma cosmetic brand.
R&G Relief & Go – a breakthrough patent-pending CBD pain relief brand.
InnoCan seeks to integrate the huge therapeutic potential of Cannabinoid, with smart synergetic combinations and delivery systems, to make an impact on global health and wellbeing.
Join us!
People In This Video
No users are tagged in this video
